ICON’s ICLR focus on Patient Access & Engagement strategy is a major tailwind along with partnerships and acquisitions. The stock carries a Zacks Rank #2 (Buy) currently. ICON is gaining from its ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent global survey of 101 biotech ...
Dave Hengartner, co-founder/CEO of rready, a SaaS startup supporting companies to unleash their biggest asset for innovation: employees. Many organizations are racing to embed AI into nearly every ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback